Rainbow Childrens Medicare Ltd (RAINBOW) — shareholding pattern, promoter holding, financials and share price

About Rainbow Childrens Medicare Ltd (RAINBOW)

Rainbow Childrens Medicare Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as RAINBOW and on the BSE under scrip code 543524. Its ISIN is INE961O01016.

Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology. [1] It is country’s largest pediatric hospital chain with 16 hospitals spread across 6 cities. [2]

Rainbow Children's Medicare Limited is a leading pediatric and obstetrics healthcare provider in India, operating 23 hospitals across 9 cities. Its network includes pediatric, neonatal, and perinatal care services, with a doctor engagement model that ensures 24/7 care by full-time specialists.

The company has seen a steady improvement in operational metrics, with a 12% revenue growth in Q3 FY26. Its focus on capacity expansion has resulted in new facilities in regions like Rajahmundry and Bengaluru, bolstering its presence in Southern India.

Listed peers in Hospital: Dr Agarwals Health Care Ltd, Park Medi World Ltd, Healthcare Global Enterprises Ltd, Jupiter Life Line Hospitals Ltd, Yatharth Hospital & Trauma Care Services Ltd, Kovai Medical Center & Hospital Ltd.

Valuation & Returns

10 Jul 2026

At ₹1,457.95 a share on 10 Jul 2026, Rainbow Childrens Medicare Ltd (RAINBOW) was valued at a price-to-earnings ratio of 52.59x against an industry P/E of 61.73x and a price-to-book of 8.98x on a book value of ₹162.28 per share as of Mar 2026. Solomo computes return on equity of 17.08% and return on capital employed of 17.17% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
52.59x
Industry P/E
61.73x
P/B
8.98x
EPS (TTM)
₹27.72
Book value / share
₹162.28
ROE
17.08%
ROCE
17.17%
ROA
10.15%
Debt / equity
0.54x
Dividend yield
0.24%
EBITDA margin
34.43%
52-week range
₹1,008.75 – ₹1,644.1

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Rainbow Childrens Medicare Ltd (RAINBOW) reported revenue of ₹1,703 crore, net profit of ₹282 crore and earnings per share of ₹27.4. That compares with revenue of ₹1,516 crore and net profit of ₹244 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹460 crore and net profit ₹78 crore (consolidated).

Consolidated annual results for Rainbow Childrens Medicare Ltd (RAINBOW), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)9741,1741,2971,5161,703
Net profit (₹ cr)139212218244282
EPS (₹)14.720.7721.3823.9727.4
Compound annual growth for Rainbow Childrens Medicare Ltd (RAINBOW). Stock price CAGR is price return and excludes dividends.
Measure10Y5Y3Y1Y
Sales growth19.07%20.26%11.53%12.35%
Profit growth25.94%38.30%6.69%15.28%
Stock price CAGR--12%-3%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 49.84% of Rainbow Childrens Medicare Ltd (RAINBOW) (unchanged from the previous quarter), foreign institutional investors (FII) hold 16.03% and domestic institutional investors (DII) hold 22.56%. Market capitalisation was ₹14,807 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Jun 2022.

Largest disclosed public shareholders in Jun 2026: ICICI PRUDENTIAL ESG EXCLUSIONARY STRATEGY FUND 5.98%, DSP NIFTY SMALLCAP 250 ETF 4.09%, FRANKLIN TEMPLETON INVESTMENT FUNDS - FRANKLIN IND 2.76%, ABU DHABI INVESTMENT AUTHORITY - MONSOON 2.13%, HDFC LIFE INSURANCE COMPANY LIMITED 1.85%, TATA MUTUAL FUND - TATA ELSS FUND 1.66%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202649.84%-16.03%22.56%49.98%
Mar 202649.84%-17.24%21.13%50.04%
Dec 202549.84%-19.23%19.49%50.12%
Sep 202549.85%-21.85%17.46%50.15%
Jun 202549.85%-23.59%15.44%50.15%
Mar 202549.85%-23.69%15.31%50.15%
Dec 202449.85%-25.12%13.87%50.15%
Sep 202449.85%-25.11%13.83%50.15%
Every quarter since Jun 2022 Filing data, not investment advice.